
Acorzone S 250mg/125mg Injection
Marketer
Alleviate Pharmaceuticals Pvt. Ltd.
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Acorzone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. It inhibits microbial growth, thus curbing infection spread. Administration must be under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if experiencing drowsiness or dizziness. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Acorzone S 250mg/125mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Acorzone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Acorzone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Acorzone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Acorzone S 250mg/125mg Injection:
Administering this medication requires a healthcare professional (doctor or nurse). Self-medication is strictly prohibited.
How Acorzone S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Acorzone S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by neutralizing bacterial enzymes that would otherwise compromise its effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Acorzone S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Acorzone S (250mg/125mg) is typically regarded as safe for use in pregnancy. Preclinical trials using animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Acorzone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Acorzone S 250mg/125mg Injection could lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Acorzone S 250mg/125mg Injection use in individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should receive Acorzone S 250mg/125mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Dosage alteration for Acorzone S 250mg/125mg Injection is unnecessary in individuals exhibiting mild to moderate liver dysfunction.
What if you forget to take Acorzone S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Acorzone S 250mg/125mg Injection, seek immediate medical advice.
Facts to Know About Acorzone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
